Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",20405,70,2.95 [2.32-3.76],1.905862053321112e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,20559,70,9.77 [5.93-16.10],3.907779771973161e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,20689,70,7.63 [5.29-10.98],1.0686968842227187e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17468,41,6.34 [4.11-9.79],6.812904855697913e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20598,70,6.88 [4.10-11.56],3.075820317286784e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21028,72,7.05 [3.47-14.32],6.61159799656544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17942,41,5.99 [3.38-10.62],9.230296329233647e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,20559,70,7.82 [4.46-13.71],7.028022032915593e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,20857,70,8.97 [4.98-16.16],2.659092231524644e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,20938,72,5.30 [3.43-8.18],5.3307877527146505e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,20698,72,2.01 [1.70-2.38],4.82199992838366e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AFP,Alpha-fetoprotein,20521,70,0.26 [0.18-0.38],3.507099966049479e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,20185,68,1.83 [1.51-2.21],7.730001816488584e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,20857,70,5.30 [3.78-7.42],3.73004597085342e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANG,Angiogenin,20755,71,4.37 [2.81-6.80],6.429532352807851e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,20973,72,4.97 [3.31-7.44],8.220336733126959e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,20823,70,6.76 [4.29-10.65],1.835049095504113e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,20973,72,3.57 [2.29-5.55],1.7681521167014855e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,20260,69,3.85 [2.36-6.29],7.304318557100534e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,18025,40,4.27 [2.91-6.27],1.2401237763606578e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOM,Apolipoprotein M,20860,71,0.15 [0.08-0.29],1.1133758196171498e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,20698,72,5.01 [3.65-6.89],2.6773786056026267e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,20893,71,5.37 [3.40-8.48],6.144516995423023e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,20598,70,6.11 [3.88-9.63],6.658620207280632e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17942,41,2.93 [2.10-4.09],2.7517686035840976e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,18025,40,2.30 [1.70-3.12],7.15663296250232e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,20311,71,5.60 [3.75-8.36],3.5540513027506086e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20755,70,5.97 [3.17-11.22],2.9542213966269162e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,20755,70,3.42 [2.46-4.76],2.6246639641274213e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,20698,72,9.38 [6.65-13.22],2.3630118748422242e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,20973,72,5.24 [3.18-8.64],7.794558294829342e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA4,Carbonic anhydrase 4,21041,72,8.68 [4.16-18.12],8.353135470627848e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,20698,72,3.62 [2.62-4.99],5.838337487450568e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,20786,71,4.75 [3.19-7.05],1.3652579886533931e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL11,Eotaxin,21028,72,4.99 [2.88-8.64],9.889361676567224e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL14,C-C motif chemokine 14,20755,71,2.50 [1.87-3.34],5.143126307319289e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,21041,72,5.66 [3.94-8.12],5.2861376589538386e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,20857,70,2.40 [1.78-3.23],8.732590068889042e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,21028,72,4.16 [2.81-6.17],1.2232962845558682e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,21002,72,6.09 [4.13-8.98],7.494438285843652e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,20973,72,4.85 [3.28-7.18],2.8292186975975644e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,20787,69,9.48 [6.07-14.82],5.391342058565726e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,20400,71,4.19 [2.78-6.33],9.746735675914449e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,21028,72,4.24 [3.12-5.76],2.2808951323223e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,20755,70,3.59 [2.28-5.66],3.546312767306864e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,20330,70,5.88 [3.57-9.70],3.896636031234065e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,20848,71,5.99 [4.41-8.14],2.2783046767410333e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,20598,70,4.25 [2.96-6.10],5.091214235032374e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,20311,71,2.74 [2.00-3.77],5.375088249696085e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,20980,71,6.71 [4.23-10.65],6.296940339556878e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,20917,72,5.76 [4.05-8.19],2.0951575484385784e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LF,CMRF35-like molecule 1,20973,72,2.80 [1.93-4.05],4.80435458038471e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300LG,CMRF35-like molecule 9,20787,69,5.05 [3.07-8.32],2.0319212096798656e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,20698,72,8.41 [5.71-12.39],4.625321733263133e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20698,72,7.75 [4.79-12.54],7.040657459692057e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,20752,70,3.04 [2.15-4.31],3.863656165896159e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,20695,70,8.56 [5.39-13.60],1.0014466367749525e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,20823,70,6.37 [3.87-10.47],2.902984301991549e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,20939,72,2.96 [2.11-4.15],3.402811186102896e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,20076,68,5.41 [3.44-8.51],2.862853739719774e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,20980,71,8.42 [5.49-12.91],1.4777186716057286e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,21028,72,3.82 [2.95-4.96],6.27932558553988e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,20755,70,6.02 [3.82-9.50],1.2082767290550676e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,20007,69,7.65 [4.56-12.85],1.3869714996106286e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,20116,69,3.42 [2.66-4.39],1.102495880583428e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,20786,71,2.30 [1.79-2.96],8.095729141010466e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,20980,71,5.25 [3.44-8.01],1.572537558629811e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,20786,71,3.57 [2.29-5.54],1.549325836236585e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,20698,72,3.68 [2.53-5.36],9.701249533828568e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,20780,70,8.83 [3.99-19.51],7.362395927333034e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,20787,69,2.26 [1.74-2.94],1.1878743753819863e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,20786,71,8.32 [5.44-12.70],1.1466168802595812e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17961,41,3.77 [2.56-5.55],2.0245117592385884e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,20927,70,5.28 [3.68-7.55],1.1136976652026925e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,18005,40,4.52 [2.94-6.97],7.593701569821137e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,20924,72,8.17 [5.47-12.19],9.33042595661443e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,18005,40,4.91 [3.17-7.62],1.0612896979485122e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,20787,69,9.80 [6.03-15.93],3.1254421008174096e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,20405,70,5.93 [3.72-9.45],6.753281816994235e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,20714,71,5.70 [3.34-9.72],1.6551249719742068e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,21028,72,4.92 [3.26-7.41],2.6357095895177352e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTN1,Contactin-1,21041,72,7.64 [3.72-15.70],3.14183754340719e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,20786,71,5.09 [3.43-7.54],5.970355221786729e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,21041,72,9.91 [7.01-14.01],1.277992929950336e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA2,Carboxypeptidase A2,20919,70,2.64 [2.00-3.48],5.345203945889363e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,20749,70,9.77 [4.69-20.37],1.1884322417885114e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,20598,70,2.60 [1.86-3.63],1.897300436422532e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSE,Cathepsin E,17589,39,4.21 [2.49-7.12],7.620042117105731e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSL,Cathepsin L1,20786,71,7.44 [3.67-15.11],2.7634586781322705e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,21028,72,6.67 [4.12-10.78],9.80867802189587e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSZ,Cathepsin Z,20829,70,9.65 [5.43-17.15],1.059208008497148e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,20598,70,4.78 [3.02-7.56],2.2842402663723315e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,20755,70,2.63 [1.90-3.64],4.782999993778666e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",20848,71,7.04 [4.31-11.51],7.137441183229559e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20698,72,2.70 [1.90-3.85],3.771314009164184e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,20560,70,4.47 [3.42-5.84],4.468767178294278e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17513,41,0.29 [0.21-0.40],4.246548696704761e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,20698,72,6.01 [3.46-10.43],1.9066393502899503e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DPY30,Protein dpy-30 homolog,20914,72,2.20 [1.75-2.76],8.345341211910156e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DRAXIN,Draxin,20598,70,4.10 [2.68-6.27],7.682393134436209e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,17907,40,3.43 [2.31-5.09],9.06565946395769e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,20698,72,6.04 [3.83-9.52],1.0150187522213571e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EBI3_IL27,Interleukin-27,20948,72,6.98 [3.95-12.36],2.512503262856563e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,20973,72,7.32 [5.36-9.99],4.412414835454538e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFNA4,Ephrin-A4,20559,70,8.17 [5.71-11.69],1.5587513550757972e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,20819,70,9.49 [4.86-18.53],4.399926151914852e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,20026,69,9.61 [6.64-13.92],4.909806569279545e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,20570,69,8.29 [5.13-13.40],6.214125963893009e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,20939,72,4.61 [2.95-7.22],2.3039054111676496e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,21041,72,9.45 [5.95-15.01],1.6890815299082497e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F2R,Proteinase-activated receptor 1,20823,70,3.44 [2.38-4.96],4.056634326812145e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",F3,Tissue factor,20838,72,9.49 [4.81-18.72],8.580878893024685e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",20749,70,2.22 [1.86-2.66],2.1122706311656885e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",18009,41,3.50 [2.52-4.84],5.2319015528986936e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",21041,72,4.00 [3.01-5.30],5.927959844495131e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAM3D,Protein FAM3D,17942,41,4.14 [2.80-6.12],9.479710561147126e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,18005,40,7.12 [3.79-13.35],9.870054328956692e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,20787,69,1.91 [1.55-2.37],2.299669064853486e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,20942,72,1.87 [1.50-2.33],2.0166452918261253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,20433,70,5.17 [3.51-7.61],7.653396378774036e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,20848,71,6.84 [3.47-13.46],2.6763081143533666e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20598,70,7.57 [4.43-12.95],1.395106745143011e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR1,Folate receptor alpha,20760,71,5.46 [3.42-8.71],1.1469851367382722e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,20980,71,7.22 [3.91-13.32],2.506418502917979e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20698,72,4.44 [2.67-7.38],9.103412014444102e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,21041,72,6.37 [4.97-8.16],1.3991514375219592e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,20335,69,3.04 [2.05-4.51],3.5943709531109726e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,20531,70,6.02 [3.26-11.11],9.36645916474494e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,17560,39,2.58 [1.89-3.51],1.7270349133422823e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,20405,70,3.46 [2.61-4.57],4.111862738447115e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,20675,69,4.70 [2.73-8.10],2.3538432720394276e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GUCA2A,Guanylin,20674,69,5.91 [3.99-8.75],7.3404431850221165e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,20939,72,3.44 [2.82-4.20],3.6088007998380404e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,20787,69,5.60 [3.78-8.30],1.0152190382353101e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20755,70,8.35 [5.32-13.09],2.366945184885492e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMBS,Porphobilinogen deaminase,20973,72,0.22 [0.14-0.35],2.4540175734622353e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17468,41,4.93 [2.85-8.55],1.2710970352746665e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,20973,72,6.48 [4.56-9.21],1.8964095951542893e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20654,70,8.74 [5.66-13.50],1.4032013834752108e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,20857,70,8.24 [4.22-16.10],6.582247631015831e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,20698,72,8.35 [4.71-14.79],3.485535929314639e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,21011,72,5.37 [3.82-7.54],3.556193876827866e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,20893,71,0.25 [0.16-0.39],1.7106419986007167e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,20536,67,4.37 [3.40-5.61],1.4615185507604032e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,20719,71,6.58 [4.58-9.44],1.5280910828093944e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,21041,72,3.65 [2.60-5.14],1.0824823534705602e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,20786,71,4.42 [2.80-6.98],1.8929432639580158e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,20786,71,5.38 [3.32-8.71],7.515031819423052e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,20857,70,5.58 [3.56-8.74],5.5917733448695287e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12A_IL12B,Interleukin-12,20698,72,2.27 [1.83-2.81],1.1302123345720278e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12B,Interleukin-12 subunit beta,21028,72,3.55 [2.52-5.00],4.148034588028921e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,20433,70,4.72 [3.04-7.33],5.135356934777814e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,20433,70,6.49 [3.82-11.00],4.080310723991152e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL17C,Interleukin-17C,20433,70,1.84 [1.52-2.23],3.044472582714617e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,20893,71,9.14 [5.75-14.55],9.524994239619182e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,21028,72,7.97 [4.53-14.03],6.130950677365248e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,20968,72,3.98 [2.59-6.11],2.8259835974981123e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,20655,70,3.18 [2.24-4.50],7.326951991448457e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,20755,70,4.28 [3.02-6.06],2.3727017764016365e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,17589,39,3.53 [2.36-5.29],9.046834761693423e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20893,71,9.83 [5.80-16.65],1.9725167114700628e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KITLG,Kit ligand,20786,71,5.18 [3.00-8.95],3.6185002984579918e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,20649,70,3.53 [2.57-4.86],9.168859018992999e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,20973,72,3.07 [2.57-3.67],7.135940180182641e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,20808,71,7.98 [4.44-14.34],3.670711431334999e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",20717,70,2.44 [1.94-3.07],1.7056433984193534e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,20698,72,2.82 [2.13-3.72],3.114490387818257e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20749,70,4.17 [3.15-5.51],1.2971986223044091e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAYN,Layilin,20570,69,8.83 [6.27-12.42],7.139516330456308e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,20176,70,3.91 [2.78-5.50],4.241576470340243e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17972,41,2.65 [1.85-3.78],8.306675890122902e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,20786,71,4.80 [3.18-7.23],7.465635441633388e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,20850,72,7.25 [4.18-12.56],1.668043323640618e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,20749,70,5.71 [4.32-7.54],2.091390570436745e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,20752,70,7.29 [4.52-11.76],3.860148374779264e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20757,71,5.44 [3.18-9.31],6.431284871894317e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20433,70,3.15 [2.13-4.67],1.0100545683299657e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,20914,72,4.27 [2.52-7.23],6.590783391977194e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,20786,71,8.20 [5.29-12.72],5.189680869543618e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,21041,72,5.83 [3.69-9.20],3.9287516527793714e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,20640,70,9.04 [5.90-13.84],4.190515577991769e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,20652,70,3.07 [2.24-4.20],2.545656635135491e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,18009,41,6.56 [3.86-11.15],3.89032899587995e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,20848,71,5.50 [3.03-9.97],2.0738389934332423e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,21041,72,2.74 [2.11-3.56],4.2723636137174425e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,20679,71,3.59 [2.30-5.60],1.6560537711622038e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,20781,71,2.51 [1.95-3.22],6.666550798988285e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,21028,72,7.26 [3.58-14.73],4.0807276397974114e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,20714,70,2.35 [1.78-3.10],1.783385826800514e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,20815,71,2.98 [2.22-4.00],3.9474641448053313e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,20376,70,6.16 [4.16-9.12],1.0667018354729846e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,20973,72,6.15 [3.71-10.21],2.028142420245801e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,20335,69,4.23 [3.18-5.63],5.08490840704165e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17383,40,2.79 [1.93-4.02],4.4265130667389854e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17942,41,5.63 [3.53-8.99],4.34389849167799e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,20848,71,5.44 [3.89-7.60],3.4248927323690013e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,20275,69,4.17 [3.24-5.36],5.867597766241521e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,20848,71,0.15 [0.10-0.23],5.001326549837013e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",20335,69,2.68 [2.10-3.42],2.3935168894661858e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,17699,40,4.61 [3.00-7.10],3.4905647278292496e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,20786,71,5.40 [3.90-7.48],4.115772098267267e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPY,Pro-neuropeptide Y,20973,72,3.79 [2.63-5.46],9.145109637116329e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,20786,71,6.14 [3.64-10.35],1.0732741283491687e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,20786,71,6.34 [3.22-12.49],9.543439597958465e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,20786,71,1.62 [1.41-1.86],8.527225917028471e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NUCB2,Nucleobindin-2,20943,72,4.49 [2.77-7.28],1.112292417232528e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OGN,Mimecan,20787,69,6.10 [4.39-8.47],3.3408085674474976e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,17838,41,4.74 [2.77-8.11],1.4767329245968044e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,17961,41,3.57 [2.27-5.61],3.1770702620111495e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,20932,72,2.59 [1.86-3.60],1.3798060452260889e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,20698,72,9.65 [5.92-15.72],9.520396714412418e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,21028,72,9.94 [6.37-15.52],4.70765828944802e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,20938,72,2.78 [1.97-3.93],7.002269451091574e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,20513,72,2.29 [1.76-2.99],9.911853240200194e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,20523,69,5.40 [3.46-8.41],9.792478723954705e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,20787,69,6.89 [4.46-10.64],2.992471202234753e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,20786,71,5.26 [3.43-8.07],2.630459649182329e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,20598,70,3.03 [2.08-4.43],9.952078686353013e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLIN3,Perilipin-3,20786,71,3.78 [2.58-5.52],7.221989800035587e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRELP,Prolargin,20749,70,9.93 [5.64-17.48],1.7979281088035567e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,18005,40,3.88 [2.43-6.20],1.28931839478366e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,17513,41,5.26 [2.99-9.25],8.565194555237932e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,20714,71,3.91 [2.42-6.32],2.6860010981290085e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,20688,70,5.03 [3.33-7.59],1.5886754662463142e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSAP,Prosaposin,17835,40,4.87 [3.06-7.76],2.770844692532461e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,20598,70,2.50 [1.93-3.23],2.364613889945484e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,20656,70,9.38 [6.53-13.48],9.397662403503701e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20755,70,2.16 [1.66-2.80],7.577456947495218e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,20335,69,4.50 [2.82-7.19],3.2508294149079577e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,20532,69,5.09 [3.48-7.46],6.666880936400004e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PYY,Peptide YY,17383,40,2.06 [1.58-2.69],9.340800826421496e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,20794,72,9.83 [5.70-16.93],1.787260277265604e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,20927,72,2.50 [1.94-3.21],9.423101871678542e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17972,41,3.21 [2.29-4.49],1.0011755887615013e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,20698,72,2.43 [1.91-3.09],4.98674544623057e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,20686,71,4.80 [3.78-6.10],4.073409936009398e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,21041,72,3.19 [2.56-3.99],1.823298888166728e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,21041,72,2.66 [2.12-3.35],5.838794096147252e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,20780,70,7.32 [5.29-10.13],3.0535453065103484e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,20787,69,5.98 [3.90-9.18],2.9705545651011043e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,20786,71,4.02 [3.32-4.86],7.894823160024821e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20698,72,5.55 [3.14-9.81],3.949254983860424e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,20734,70,2.93 [2.15-3.99],8.311431110968598e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RGMA,Repulsive guidance molecule A,20980,71,5.59 [2.98-10.47],8.001711331367003e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,18023,40,6.17 [3.46-11.01],7.534544857225201e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17513,41,6.58 [3.58-12.09],1.277855416764395e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,20973,72,8.79 [5.75-13.42],8.081163746817901e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RTN4R,Reticulon-4 receptor,20973,72,5.11 [3.55-7.35],1.4379943203589505e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,20187,70,6.39 [4.54-9.00],2.0053636919943238e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,21041,72,4.06 [2.62-6.28],3.4060909476192576e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCG3,Secretogranin-3,20780,70,5.83 [3.26-10.44],2.9509967486246907e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGB1A1,Uteroglobin,20791,70,3.45 [2.27-5.24],5.8288597660605954e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,20433,70,4.95 [3.57-6.86],9.26962787124659e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,17513,41,5.96 [3.56-10.01],1.3372477474415262e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA3F,Semaphorin-3F,20786,71,9.90 [4.93-19.88],1.1291201597486839e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEZ6L,Seizure 6-like protein,20848,71,9.04 [5.09-16.05],5.788075224679586e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,20521,70,2.35 [1.80-3.05],2.1334124023058947e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,18005,40,5.10 [3.02-8.63],1.1924669233029014e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,20857,70,4.03 [2.86-5.67],1.5650420590804285e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,20755,70,3.91 [2.67-5.74],2.6161441565999588e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,20973,72,5.00 [3.33-7.49],6.474779296868951e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,20711,70,5.34 [3.74-7.61],2.6590256710624526e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,20973,72,4.64 [2.97-7.26],1.5442278258013434e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,20405,70,3.42 [2.23-5.24],1.81407243929159e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,20973,72,4.96 [3.18-7.74],1.5682750153299157e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,20857,70,6.10 [4.26-8.75],7.069068201217074e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,20598,70,3.48 [2.59-4.68],1.4237635820760626e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,20311,71,8.48 [5.55-12.96],5.420143013953799e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SOST,Sclerostin,20757,71,4.36 [2.56-7.41],5.40644954231696e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,20787,69,7.55 [5.59-10.18],7.516006622657859e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,20755,70,3.69 [2.94-4.63],2.316168178303488e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,20857,70,5.80 [3.70-9.10],1.8789288306535668e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,20780,70,6.56 [4.33-9.95],8.341856793166544e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,20698,72,6.98 [4.91-9.92],2.9493290363908354e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,21011,72,6.46 [4.48-9.30],1.2396410660313901e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,20689,69,2.26 [1.87-2.74],8.368615039227791e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,20823,70,3.74 [2.85-4.91],1.7663377605315633e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,20796,72,3.80 [2.97-4.86],3.192742369052979e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFA,Protransforming growth factor alpha,20755,70,3.28 [2.33-4.60],7.299508292602263e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,20848,71,6.56 [4.76-9.05],1.4645345714286064e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,21041,72,6.58 [3.67-11.80],2.6021664653483177e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBD,Thrombomodulin,20786,71,6.61 [4.05-10.79],4.0854312134990614e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,20980,71,9.64 [5.73-16.21],1.3288307253965521e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,20596,70,6.44 [3.89-10.68],4.925573822610236e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20598,70,4.06 [2.76-5.97],9.691634178742965e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20598,70,1.73 [1.47-2.04],4.079213212588834e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21028,72,9.18 [6.59-12.80],3.418670703178579e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20749,70,4.79 [2.81-8.16],7.932714620523776e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20848,71,6.97 [4.84-10.04],1.461244539646154e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20780,70,2.71 [2.03-3.61],1.0139088803723244e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20973,72,6.21 [4.42-8.72],6.373916866312289e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20787,69,2.87 [2.29-3.62],1.939188714807425e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20980,71,8.22 [4.82-14.02],9.652963859422076e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20995,72,5.86 [4.24-8.09],6.966811119104231e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20598,70,3.00 [2.36-3.81],2.988971409517449e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,20598,70,5.54 [3.90-7.85],7.757933860962568e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,20968,71,0.30 [0.22-0.40],3.820903900149835e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,20860,71,7.44 [4.20-13.20],6.3842737723212975e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,21002,72,5.74 [3.43-9.63],3.2739693463381486e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17945,40,2.87 [2.11-3.91],2.419996816430632e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,20760,68,6.92 [4.94-9.70],2.156565367739344e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VWC2,Brorin,20531,69,9.34 [5.92-14.74],7.97065140200277e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,19746,66,4.24 [3.20-5.63],1.4633544900106962e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,20433,70,8.06 [5.24-12.40],1.972857523376819e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XCL1,Lymphotactin,20973,72,2.02 [1.59-2.56],9.417089960842371e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",XG,Glycoprotein Xg,20948,72,7.45 [5.25-10.58],2.5432973346423346e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,17961,41,7.52 [4.34-13.03],6.720722328603937e-13
